Login to Your Account

Financings Roundup

Tuesday, December 20, 2011
• Medicago Inc., of Quebec City, closed the second tranche of a C$22.5 million (US$21.8 million) private placement by Philip Morris Investments BV, consisting of 17.2 million common shares at C65 cents per share for gross proceeds of C$11.2 million. The first tranche, which closed in October, was a similar size. The proceeds will be used to advance Medicago's pandemic and seasonal influenza vaccine candidates. Philip Morris' investment stems from a rights agreement between the companies executed in 2008.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription